Monitoring immune-checkpoint blockade: response evaluation and biomarker development
Nishino, Mizuki, Ramaiya, Nikhil H., Hatabu, Hiroto, Hodi, F. Stephen
Published in Nature reviews. Clinical oncology (01.11.2017)
Published in Nature reviews. Clinical oncology (01.11.2017)
Get full text
Journal Article
Combined Nivolumab and Ipilimumab in Melanoma Metastatic to the Brain
Tawbi, Hussein A, Forsyth, Peter A, Algazi, Alain, Hamid, Omid, Hodi, F. Stephen, Moschos, Stergios J, Khushalani, Nikhil I, Lewis, Karl, Lao, Christopher D, Postow, Michael A, Atkins, Michael B, Ernstoff, Marc S, Reardon, David A, Puzanov, Igor, Kudchadkar, Ragini R, Thomas, Reena P, Tarhini, Ahmad, Pavlick, Anna C, Jiang, Joel, Avila, Alexandre, Demelo, Sheena, Margolin, Kim
Published in The New England journal of medicine (23.08.2018)
Published in The New England journal of medicine (23.08.2018)
Get full text
Journal Article
Cytotoxic T lymphocyte antigen-4 and immune checkpoint blockade
Buchbinder, Elizabeth, Hodi, F Stephen
Published in The Journal of clinical investigation (01.09.2015)
Published in The Journal of clinical investigation (01.09.2015)
Get full text
Journal Article
Hepatotoxicity with Combination of Vemurafenib and Ipilimumab
Ribas, Antoni, Hodi, F. Stephen, Callahan, Margaret, Konto, Cyril, Wolchok, Jedd
Published in The New England journal of medicine (04.04.2013)
Published in The New England journal of medicine (04.04.2013)
Get full text
Journal Article
Metabolomic adaptations and correlates of survival to immune checkpoint blockade
Li, Haoxin, Bullock, Kevin, Gurjao, Carino, Braun, David, Shukla, Sachet A., Bossé, Dominick, Lalani, Aly-Khan A., Gopal, Shuba, Jin, Chelsea, Horak, Christine, Wind-Rotolo, Megan, Signoretti, Sabina, McDermott, David F., Freeman, Gordon J., Van Allen, Eliezer M., Schreiber, Stuart L., Stephen Hodi, F., Sellers, William R., Garraway, Levi A., Clish, Clary B., Choueiri, Toni K., Giannakis, Marios
Published in Nature communications (25.09.2019)
Published in Nature communications (25.09.2019)
Get full text
Journal Article
Immune-Modified Response Evaluation Criteria In Solid Tumors (imRECIST): Refining Guidelines to Assess the Clinical Benefit of Cancer Immunotherapy
Hodi, F Stephen, Ballinger, Marcus, Lyons, Benjamin, Soria, Jean-Charles, Nishino, Mizuki, Tabernero, Josep, Powles, Thomas, Smith, David, Hoos, Axel, McKenna, Chris, Beyer, Ulrich, Rhee, Ina, Fine, Gregg, Winslow, Nathan, Chen, Daniel S, Wolchok, Jedd D
Published in Journal of clinical oncology (20.03.2018)
Published in Journal of clinical oncology (20.03.2018)
Get full text
Journal Article
The Activation of MAPK in Melanoma Cells Resistant to BRAF Inhibition Promotes PD-L1 Expression That Is Reversible by MEK and PI3K Inhibition
XIAOFENG JIANG, JUN ZHOU, GIOBBIE-HURDE, Anita, WARGO, Jennifer, STEPHEN HODI, F
Published in Clinical cancer research (01.02.2013)
Published in Clinical cancer research (01.02.2013)
Get full text
Journal Article
Pooled Analysis of Long-Term Survival Data From Phase II and Phase III Trials of Ipilimumab in Unresectable or Metastatic Melanoma
Schadendorf, Dirk, Hodi, F Stephen, Robert, Caroline, Weber, Jeffrey S, Margolin, Kim, Hamid, Omid, Patt, Debra, Chen, Tai-Tsang, Berman, David M, Wolchok, Jedd D
Published in Journal of clinical oncology (10.06.2015)
Published in Journal of clinical oncology (10.06.2015)
Get full text
Journal Article
Endocrine Toxicity of Cancer Immunotherapy Targeting Immune Checkpoints
Chang, Lee-Shing, Barroso-Sousa, Romualdo, Tolaney, Sara M, Hodi, F Stephen, Kaiser, Ursula B, Min, Le
Published in Endocrine reviews (01.02.2019)
Published in Endocrine reviews (01.02.2019)
Get full text
Journal Article
Anti–PD-1–Related Pneumonitis during Cancer Immunotherapy
Nishino, Mizuki, Sholl, Lynette M, Hatabu, Hiroto, Ramaiya, Nikhil H, Hodi, F. Stephen
Published in The New England journal of medicine (16.07.2015)
Published in The New England journal of medicine (16.07.2015)
Get full text
Journal Article
Antibody-mediated inhibition of MICA and MICB shedding promotes NK cell-driven tumor immunity
Ferrari de Andrade, Lucas, Tay, Rong En, Pan, Deng, Luoma, Adrienne M, Ito, Yoshinaga, Badrinath, Soumya, Tsoucas, Daphne, Franz, Bettina, May, Jr, Kenneth F, Harvey, Christopher J, Kobold, Sebastian, Pyrdol, Jason W, Yoon, Charles, Yuan, Guo-Cheng, Hodi, F Stephen, Dranoff, Glenn, Wucherpfennig, Kai W
Published in Science (American Association for the Advancement of Science) (30.03.2018)
Published in Science (American Association for the Advancement of Science) (30.03.2018)
Get full text
Journal Article
Efficacy and Safety Outcomes in Patients With Advanced Melanoma Who Discontinued Treatment With Nivolumab and Ipilimumab Because of Adverse Events: A Pooled Analysis of Randomized Phase II and III Trials
Schadendorf, Dirk, Wolchok, Jedd D, Hodi, F Stephen, Chiarion-Sileni, Vanna, Gonzalez, Rene, Rutkowski, Piotr, Grob, Jean-Jacques, Cowey, C Lance, Lao, Christopher D, Chesney, Jason, Robert, Caroline, Grossmann, Kenneth, McDermott, David, Walker, Dana, Bhore, Rafia, Larkin, James, Postow, Michael A
Published in Journal of clinical oncology (01.12.2017)
Published in Journal of clinical oncology (01.12.2017)
Get full text
Journal Article
Ipilimumab for Patients with Relapse after Allogeneic Transplantation
Davids, Matthew S, Kim, Haesook T, Bachireddy, Pavan, Costello, Caitlin, Liguori, Rebecca, Savell, Alexandra, Lukez, Alexander P, Avigan, David, Chen, Yi-Bin, McSweeney, Peter, LeBoeuf, Nicole R, Rooney, Michael S, Bowden, Michaela, Zhou, Chensheng W, Granter, Scott R, Hornick, Jason L, Rodig, Scott J, Hirakawa, Masahiro, Severgnini, Mariano, Hodi, F. Stephen, Wu, Catherine J, Ho, Vincent T, Cutler, Corey, Koreth, John, Alyea, Edwin P, Antin, Joseph H, Armand, Philippe, Streicher, Howard, Ball, Edward D, Ritz, Jerome, Bashey, Asad, Soiffer, Robert J
Published in The New England journal of medicine (14.07.2016)
Published in The New England journal of medicine (14.07.2016)
Get full text
Journal Article
Ipilimumab and Its Toxicities: A Multidisciplinary Approach
Fecher, Leslie A., Agarwala, Sanjiv S., Hodi, F. Stephen, Weber, Jeffrey S.
Published in The oncologist (Dayton, Ohio) (01.06.2013)
Published in The oncologist (Dayton, Ohio) (01.06.2013)
Get full text
Journal Article
Phase I/Ib Clinical Trial of Sabatolimab, an Anti-TIM-3 Antibody, Alone and in Combination with Spartalizumab, an Anti-PD-1 Antibody, in Advanced Solid Tumors
Curigliano, Giuseppe, Gelderblom, Hans, Mach, Nicolas, Doi, Toshihiko, Tai, David, Forde, Patrick M, Sarantopoulos, John, Bedard, Philippe L, Lin, Chia-Chi, Hodi, F Stephen, Wilgenhof, Sofie, Santoro, Armando, Sabatos-Peyton, Catherine A, Longmire, Tyler A, Xyrafas, Alexandros, Sun, Haiying, Gutzwiller, Sabine, Manenti, Luigi, Naing, Aung
Published in Clinical cancer research (01.07.2021)
Published in Clinical cancer research (01.07.2021)
Get full text
Journal Article
Developing a Common Language for Tumor Response to Immunotherapy: Immune-Related Response Criteria Using Unidimensional Measurements
NISHINO, Mizuki, GIOBBIE-HURDER, Anita, GARGANO, Maria, SUDA, Margaret, RAMAIYA, Nikhil H, HODI, F. Stephen
Published in Clinical cancer research (15.07.2013)
Published in Clinical cancer research (15.07.2013)
Get full text
Journal Article
Molecular Pathways of Colon Inflammation Induced by Cancer Immunotherapy
Luoma, Adrienne M., Suo, Shengbao, Williams, Hannah L., Sharova, Tatyana, Sullivan, Keri, Manos, Michael, Bowling, Peter, Hodi, F. Stephen, Rahma, Osama, Sullivan, Ryan J., Boland, Genevieve M., Nowak, Jonathan A., Dougan, Stephanie K., Dougan, Michael, Yuan, Guo-Cheng, Wucherpfennig, Kai W.
Published in Cell (06.08.2020)
Published in Cell (06.08.2020)
Get full text
Journal Article